These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6341763)

  • 1. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man.
    Waldhäusl WK; Bratusch-Marrain PR; Vierhapper H; Nowotny P
    Metabolism; 1983 May; 32(5):478-86. PubMed ID: 6341763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of gonadotropin-releasing hormone: comparison of subcutaneous and intravenous routes.
    Handelsman DJ; Jansen RP; Boylan LM; Spaliviero JA; Turtle JR
    J Clin Endocrinol Metab; 1984 Oct; 59(4):739-46. PubMed ID: 6384253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption kinetics of regular insulin in dogs with alloxan-induced diabetes mellitus.
    Nelson RW; Brown SA; Jones RJ; Smith P; Bottoms GD
    Am J Vet Res; 1990 Oct; 51(10):1671-4. PubMed ID: 2240788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements.
    Ma X; Benson CT; Prescilla R; Zhang S; Linnebjerg H; LaBell ES; Morrow LA; Jackson JA; Nguyen A; Ilag LL; Johnson JL; Leishman D
    J Diabetes Sci Technol; 2022 Mar; 16(2):401-407. PubMed ID: 33242998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose.
    Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C
    Metabolism; 1981 May; 30(5):439-42. PubMed ID: 6112654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection.
    Murat A; Slama G
    Metabolism; 1985 Feb; 34(2):120-3. PubMed ID: 3881645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
    Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG
    Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men.
    Pickup JC; Bilous RW; Viberti GC; Keen H; Jarrett RJ; Glynne A; Cauldwell J; Root M; Rubenstein AH
    Diabetes Care; 1982; 5 Suppl 2():29-34. PubMed ID: 6765536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A
    Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
    Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the pharmacokinetics of human protamine sodium insulin with human isophane insulin following subcutaneous injection in normal subjects.
    Burke B; Andrews WJ; Hadden DR
    Diabetes Res; 1987 Apr; 4(4):163-7. PubMed ID: 3304782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.
    Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD
    Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
    Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Pharmacokinetic Profile of Ultra Rapid Lispro Administered Subcutaneously at Different Injection Sites.
    Leohr JK; Dellva MA; LaBell E; Coutant DE; Linnebjerg H
    Clin Ther; 2022 Jun; 44(6):836-847. PubMed ID: 35577602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.